Sowell Financial Services LLC Agios Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$52.06 - $61.27 $110,679 - $130,260	-2,126 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$44.23 - $57.5 $39,055 - $50,772	-883 Reduced 29.35%	2,126 $117,000
Q4 2020 Jan 13, 2021	BUY	$33.21 - $46.54 $99,596 - $139,573	2,999 Added 29990.0%	3,009 $130,000
Q3 2020 Nov 12, 2020	SELL	$33.87 - $55.93 $3,048 - $5,033	-90 Reduced 90.0%	10 $0
Q4 2019 Feb 07, 2020	SELL	$30.08 - $50.59 $902 - $1,517	-30 Reduced 23.08%	100 $4,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $4,212 - $6,445	130 New	130 $4,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.